<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00764075</url>
  </required_header>
  <id_info>
    <org_study_id>CRT-Study</org_study_id>
    <nct_id>NCT00764075</nct_id>
  </id_info>
  <brief_title>Guided Placement of CRT-Leads</brief_title>
  <acronym>EK138/08</acronym>
  <official_title>CT and 3D-Echocardiography Placement of CRT-Leads</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this open, prospective, randomized, parallel group, German-American, two-center, Phase I
      study the standard-approach CRT-implantation will be compared to a guided CRT-implantation
      after determining the site of latest contraction and placement of the electrode as close as
      possible to this site, using a 5-step-scheme of imaging methods determining the site of
      latest contraction prior to implantation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be allocated to two groups with either

        1. Guided implantation of the left ventricular lead

        2. Empirical implantation of the left ventricular lead (current clinical standard)

      For Treatment Group a) the target vessel, which is the vessel with smallest distance between
      RLC and CVS is determined in advance and provided to the implanting physician. In case, this
      vessel is not amenable for lead positioning, a second vessel which is the second closest to
      the RLC is defined.

      For Treatment Group b), the physician has to choose the vessel where to place the electrode
      without knowing the exact spatial orientation between that particular side-branch and the
      RLC.

      In all patients, standard biventricular devices and leads are to be used. Aspects that are
      evaluated are:

        1. Technical success in placing the electrode in the target vessel.

        2. Failure due to dislocation during the implantation procedure or phrenic nerve
           stimulation.

      Also, procedure duration, radiation exposure, and complications occurring during the
      procedure as well as post- operatively will be documented.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of non-responders regarding ejection fraction</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>rate of non-responders regarding NYHA-classification, left end-diastolic and end-systolic volume</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">132</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>guided implantation of the left ventricular lead</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>standard implantation of the left ventricular lead</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pilot Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>feasibility of guided placement of CRT-leads in 20 Patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Beutel TM</intervention_name>
    <description>application of BeutelTM</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard</intervention_name>
    <description>standard procedure will be applied but no Beutel TM software</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>software Beutel TM</intervention_name>
    <description>application of BeutelTM to patients data for determination of site of latest contraction</description>
    <arm_group_label>Pilot Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Congestive heart failure,

          -  Ejection fraction &lt;35%,

          -  Complete left bundle branch block &gt;120ms,

          -  NYHA II,III or IV

        Exclusion Criteria:

          -  Patients not fulfilling the inclusion criteria or not capable/mental able to
             understand and follow the instructions;

          -  Impaired kidney function (GFR &lt;30ml/min;

          -  Pregnant or breastfeeding women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Knackstedt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>RWTH Aachen University Departement of Cardiology, Pulmonology and Vascular Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Medicine, Division of Cardiology, Pulmonology and Vascular Medicine</name>
      <address>
        <city>Aachen</city>
        <state>NRW</state>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2008</study_first_submitted>
  <study_first_submitted_qc>September 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2008</study_first_posted>
  <last_update_submitted>July 6, 2011</last_update_submitted>
  <last_update_submitted_qc>July 6, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 7, 2011</last_update_posted>
  <responsible_party>
    <name_title>Christian Knackstedt, MD</name_title>
    <organization>RWTH Aachen University</organization>
  </responsible_party>
  <keyword>heart failure; EF&lt;35%; NYHA II, III or IV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

